Biotech

All Articles

Zephyrm seeks Hong Kong IPO to fund phase 3 tissue treatment trials

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock exchange, declaring (PDF) for an...

Frazier Life Sciences gets $630M for little, mid-cap biotechs

.Frazier Daily life Sciences has sourced an even further $630 thousand for its own fund paid attenti...

GigaGen amasses approximately $135M BARDA bucks to beat botulism

.Antibody enthusiast GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its own special...

GPCR agency Septerna apply for IPO on stamina of preclinical records

.Septerna will figure out how a biotech without "any sort of meaningful clinical information" meals ...

Kurma shuts to begin with $154M haul for biggest biotech fund as yet

.European VC firm Kurma Partners has revealed its own most current biotech fund, along with 140 thou...

Prothena ensures one exec while another keeps-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of substantial management hirings, shootings...

Editas profit Vertex Cas9 licensing civil rights for $57M

.Versus the background of a Cas9 license fight that declines to perish, Editas Medication is actuall...

Ultragenyx changes genetics therapy dosing to dial up effectiveness

.A minority of people taking Ultragenyx Drug's Wilson disease gene treatment UX701 have actually gon...

Biopharma unemployment price maintains in Q3: Tough Biotech analysis

.As summer warmth counts on cool winds, wishes that this year would certainly carry extensive busine...

J &amp J falls phase 2 dengue prospect in newest switch from vaccinations

.Johnson &amp Johnson's deprioritization of its contagious disease pipe has stated one more prey suc...